期刊文献+

阿尔茨海默病源性轻度认知功能损害生物学标志物研究进展 被引量:2

下载PDF
导出
摘要 阿尔茨海默病(Alzheimer’s Disease,AD)是一种与老化密切相关的、以认知功能障碍为主要临床特征的神经退行性疾病,其典型病理特征是老年斑(senileplaquesSPs)、神经原纤维缠结(neurofibrillarytangles NFTs)和广泛的神经元缺失等。AD的发病率高,病程长,已成为严重危害老年人身心健康的主要疾病,给社会、家庭带来沉重的负担。
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2013年第9期847-850,共4页 Journal of Apoplexy and Nervous Diseases
基金 广西卫生厅重点课题基金项目(重2012066)
  • 相关文献

参考文献42

  • 1Sperling RA,Aisen PS,Beckett LA,Bennett DA,Craft S,Fagan AM,Iwatsubo T,Jack CR Jr,Kaye J,Montine TJ,Park DC,Reiman EM,Rowe CC,Siemers E,Stern Y,Yaffe K,Carrillo MC,Thies B,Morrison-Bogorad M,Wagster MV,Phelps CH,贾建平(译),郭起浩(译),黄丽(译),陆璐(译),张逸驰(译),邢怡(译).美国国立老化研究所与阿尔茨海默病协会诊断指南写作组:阿尔茨海默病临床前阶段的定义[J].中华神经科杂志,2012,45(5):336-344. 被引量:22
  • 2McKhann GM,Knopman DS,Chertkow H,Hyman BT,Jack CR Jr,Kawas CH,Klunk WE,Koroshetz WJ,Manly JJ,Mayeux R,Mohs RC,Morris JC,Rossor MN,Schehens P,Carrillo MC,Thies B,Weintraub S,Phelps CH,贾建平(译),陆璐(译),张逸驰(译),黄丽黄(译),礼媛(译).美国国立老化研究所与阿尔茨海默病协会诊断指南写作组:阿尔茨海默病源性轻度认知障碍诊断标准推荐[J].中华神经科杂志,2012,45(5):345-351. 被引量:53
  • 3Schneider P,Buerger K,Teipel S,et al. Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer' s disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment[J]. Biol Psychiatry,2011,70(2) :145 -151.
  • 4Baker LD,Frank LL,Foster-Schubert K, et al. Effects of aerobic ex- ercise on mild cognitive impairment :a controlled trial [ J ]. Arch Neu- rol,2010,67( 1 ) :71 -79.
  • 5Welge V, Fiege O, Lewczuk P, et al. Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer' s disease [ J ]. J Neural Transm ,2009,116 (2) :203 - 212.
  • 6Pijnenbarg YA, Mulder JL,van Swieten JC, et al. Diagnostic accura- cy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population[ J]. Dement Geriatr Cogn Disord ,2008,25.(2) :157 - 164.
  • 7Diniz BS, Pinto JJ, Forlenza OV. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer' s disease ? A systematic review and meta-a- nalysis of the literature [ J ]. World J Biol Psychiatry, 2008,9 ( 3 ) : 172 - 182.
  • 8Kester MI,Verwey NA,van Elk EJ,et al. Progression from MCI to AD : predictive value of CSF Abetag2 is modified by APOE genotype [J]. Neurobiol Aging,2011,32(8) :1372 - 1378.
  • 9Buchhave P, Minthon L, Zetterberg H, et al. Cerebrospinal fluid lev- els of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia[J]. Arch Gen Psy- chiatry,2012,69( 1 ) :98 - 106.
  • 10Riemenschneider M, Lautenschlager N, Wagenpfeil S, et al. Cere- brospinal fluid tan and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment[J]. Arch Neu- rol,2002,59 ( 11 ) : 1729 - 1734.

二级参考文献90

  • 1Morris JC. Early-stage and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord, 2005,19 : 163-165.
  • 2Dubois B, Feldman HI-I, Jacova C, et al. Revising the definition of Alzheimer' s disease: a new lexicon. Lancet Neurol, 2010, 9 : 1118-1927.
  • 3Pimplikar SW, Nixon RA, Robakis NK, et al. Amyloid- independent mechanisms in Alzheimer' s disease patbogenesis. J Neurosci, 2010, 30:14946-14954.
  • 4Herrup K. Reimagining Alzheimer' s disease--an age-based hypothesis. J Neurosci, 2010, 30:16755-16762.
  • 5Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased Clearance of CNS { betat-Amyloid in Alzheimer' s Disease. Science, 2010, 330:1774.
  • 6Selkoe DJ. Alzheimer' s disease is a synaptic failure. Science, 2002, 298:789-791.
  • 7Lee HG, Casadesus G, Zhu X, et al. Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann N Y Acad Sci, 2004, 1019:1-4.
  • 8Shankar GM, Li S, Mehta TH, et al. Amyloid-beta protein dimers isolated directly from Alzheimer' s brains impair synaptic plasticity and memory. Nat Med, 2008, 14:837-842.
  • 9Yaffe K, Fiocco AJ, Lindquist K, et al. Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology, 2009, 72:2029-2035.
  • 10Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol, 2004, 61:661-666.

共引文献70

同被引文献26

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部